Basal Ganglia Atlas: Brain's Movement Centre Mapped Cell by Cell

By The Global Spy

Glowing 3D illustration of the basal ganglia highlighted deep inside a translucent human brain

For the first time, scientists have mapped one of the brain's most important regions cell by cell. On 12 November 2026, the NIH BRAIN Initiative Cell Atlas Network (BICAN) published a comprehensive atlas of the basal ganglia, a cluster of structures deep inside the brain that turns thoughts into actions. The work, published as a package of 27 papers across the journals Cell, Cell Reports Medicine, Cell Systems, Cell Genomics and Neuron, catalogues the identity, activity and location of 25.5 million individual cells.

It is the most detailed map of this region ever made, and it arrives with a clear purpose: to give researchers a reliable reference for understanding some of the hardest diseases in medicine, from Parkinson's and Huntington's to schizophrenia and addiction. The atlas itself is not a treatment. What it does is quieter and arguably more important: it tells scientists exactly which cells live where in this part of the brain, what those cells do, and how they differ between people, between species, and across a lifetime.

What is the basal ganglia, and why does it matter?

The basal ganglia are a group of interconnected structures buried deep beneath the brain's outer cortex. If the cortex is where conscious thought happens, the basal ganglia are where thought becomes action. They act as a kind of gatekeeper: deciding which movements to start, which to stop, and which habits to run automatically. They also help shape learning, motivation, decision-making and mood.

That gatekeeping role explains why the region matters so much in disease. When basal ganglia circuits go wrong, the consequences are visible and often devastating. In Parkinson's disease, the loss of dopamine-producing cells disrupts movement. In Huntington's disease, the gradual death of striatum neurons erodes control of movement and thought. The region is also tied to schizophrenia, bipolar disorder, obsessive-compulsive disorder (OCD), addiction and Alzheimer's disease. Until now, researchers studying these conditions have worked without a complete parts list: they knew the broad anatomy, but not the full cast of cell types or where each type sits.

The new atlas changes that. It is, in the words of the Allen Institute, which led much of the work, the first major working model of a standardised, cross-species brain cell reference atlas. Think of it less like a photograph and more like a city map that labels every building, street and neighbourhood, and tells you who lives in each one.

How scientists mapped 25.5 million cells

The scale of the project is hard to overstate. Hundreds of scientists from more than 55 institutions in nine countries took part, including teams at the Allen Institute and Princeton University. The work was funded by the US National Institutes of Health (NIH) through its BRAIN Initiative, a project launched in 2022 to produce reference maps of mammalian brains.

Using single-cell sequencing, which measures which genes are switched on inside a single cell, the researchers profiled 25.5 million cells from donated postmortem human brain tissue, and from rhesus and cynomolgus macaques and common marmosets. Advanced imaging techniques then linked each cell's molecular profile to a three-dimensional position inside the basal ganglia, so the atlas records not just what a cell is, but where it sits. Data from earlier whole-mouse-brain maps was also folded in, giving researchers a way to connect the new atlas to the animal models they use in the laboratory.

The result covers both neurons, the brain's signalling cells, and glial cells, their support cells, in the mature brain and during early development. That developmental dimension matters: by mapping the region as it forms, the atlas offers clues about how the basal ganglia emerge, and how early disruptions might set the stage for later disease.

Neuroscientists examining colourful single-cell brain maps on large screens in a modern laboratory

The numbers behind the atlas

The headline figure is 25.5 million cells, but the breakdown is what makes the atlas powerful. The overwhelming majority of the cells profiled were human, which grounds the atlas in the species it is ultimately meant to help, while the monkey data lets researchers compare across primates and work out which features are ancient and shared, and which are uniquely human.

Bar chart showing cells profiled for the basal ganglia atlas by species: 21.0 million human, 3.0 million macaque, 1.5 million marmoset

Comparing the three primate species, the researchers identified 61 cell types that have been conserved over 76 million years of evolution, a striking reminder that the basic machinery of this brain region is very old. They also found six zones in the human and macaque striatum, the basal ganglia's busy intake point, each with its own distinct molecular signature and mix of neurons and glial cells. These zones give researchers new, precise places to look when a disease strikes.

For readers who follow genetics, the atlas is a close cousin of the DNA-scale work now reshaping biology: where our look at DeepMind's AlphaGenome 2 DNA model showed how AI can read the genome, the basal ganglia atlas shows how to read the brain's cells one by one. Both point in the same direction: biology is moving from averages to individual cells and individual letters of DNA.

Early discoveries: a rare neuron and new clues about disease

The BICAN package already contains early examples. One of the most striking is a rare neuron found in the striatum, known by its molecular signature as STR D2 SMYD2-HTR7. It had not been clearly recognised before, and early evidence suggests it may play a role in schizophrenia — a lead, not a proven link. It is exactly the kind of discovery a cell-by-cell map makes possible: a cell type so rare that it disappears in bulk measurements, visible only when cells are examined individually.

Another group used the atlas as a blueprint to re-analyse genetic data from people with autism. Organising that data against the new reference revealed possible disruptions in certain striatum cell populations that standard methods would probably have missed — a hint that circuits deeper in the brain, not just the cortex, may be involved in autism.

A third study points toward treatment, though only in animals so far. Building on earlier BRAIN Initiative work on genetic switches called enhancers, which can target specific brain cells with high precision, scientists used one enhancer to boost levels of a dopamine precursor inside striatum cells in mouse models of Parkinson's disease. The precision delivery eased symptoms while reducing the severity of common side effects. That result is in mice, not people, and the leap to humans is long and uncertain — but it shows the kind of targeted therapy the atlas could enable: treatments aimed at one cell type in one place, rather than drugs that wash across the whole brain. The same logic of precision genetic medicine is behind our report on the one-time gene edit that freed sickle cell patients, where getting the right change into the right cells made all the difference.

What the atlas does, and what it does not do

It is worth being plain about the limits, because brain-mapping announcements are often over-sold. The basal ganglia atlas is a reference map, not a treatment. Nobody will be cured by a map. It does not by itself explain consciousness, free will, or why a particular person develops Parkinson's. And the diseases it touches are among the most complex in medicine, shaped by genes, environment, ageing and chance in combinations no single dataset can untangle.

What the atlas does is remove a bottleneck. Before it existed, a researcher studying a gene linked to Huntington's disease might know the gene mattered, but not which cells in the basal ganglia actually used it, or when in development it switched on. Now they can look it up. A drug developer can ask which cell types carry a target receptor and design a therapy that reaches those cells and spares the rest; a geneticist can ask whether schizophrenia risk genes cluster in one rare cell type rather than spreading thinly across the region.

The brain's daily rhythms matter here too. The circuits the atlas maps do not operate in isolation from the rest of life: sleep, stress and routine all shape how well they work, which is why our guide to the science of sleep debt is a useful companion read for anyone thinking about brain health. The atlas maps the hardware; how we treat that hardware day to day is a separate, and equally real, part of the story.

Microscopic view of glowing brain neurons and glial cells with branching dendrites

Why open data changes the field

Perhaps the most consequential decision in the whole project is not a scientific result at all: the data is openly available. BICAN has released the atlases and the tools to use them, including open-source software and a web-based platform that lets researchers visually explore the basal ganglia without specialist bioinformatics hardware. A management platform called NIMP lets scientists project their own tissue samples onto the standardised 3D atlas, so results from different labs can be compared directly.

That openness matters because brain science has a reproducibility problem. Different labs have long used different names for the same cell types and different boundaries for the same structures. A shared reference atlas, with a shared naming system across species, works like a common language. The Allen Institute has called it a biological Rosetta Stone, and the comparison is apt: once everyone is reading the same map, findings can accumulate instead of being lost in translation.

There is also a practical argument. A single lab could never afford to profile 25.5 million cells. By pooling the work across more than 55 institutions and then giving the result away, BICAN has handed every neuroscience lab a dataset it could not have built alone — including small labs and labs without large sequencing facilities.

What comes next: the whole brain

The basal ganglia is only the first major milestone. BICAN's stated goal is a complete parts list for the entire human brain, an atlas of every cell type, and the team hopes to extend the work to a full-brain atlas within the next few years, with coverage putting the target at around 2028.

As the NIH's BRAIN Initiative director John Ngai put it when the atlas was announced: "Representing the brain at this level of granularity opens so many opportunities to better understand basic brain function and the cellular underpinnings of devastating neurologic, neuropsychiatric, and substance use disorders."

The atlas will not make headlines again tomorrow. Its value will show up slowly, in papers that cite it, in drug targets that turn out to be real, and in diseases that become a little less mysterious. For now, the map exists, it is open, and the brain's behavioural gatekeeper finally has a parts list.

Sources

The Global Spy

The Global Spy is Platform where You find Latest And Authentic News. You will Get real Feature Stories all around the World.

If you Have Any Doubts Please Let me Know

Previous Post Next Post

نموذج الاتصال